On August 17, 2018 Emergent BioSolutions Inc. (NYSE: EBS) reported that a member of the company’s senior management team will participate in the following investor conferences during the third quarter and early portion of the fourth quarter of 2018 (Press release, Emergent BioSolutions, AUG 17, 2018, View Source;p=RssLanding&cat=news&id=2364006 [SID1234529226]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Three Part Advisors – 2018 Midwest IDEAS Investor Conference
Chicago, IL
August 29-30, 2018

Wells Fargo Securities – 2018 Healthcare Conference
Boston, MA
September 5-6, 2018

Robert W. Baird & Co. – 2018 Global Healthcare Conference
New York, NY
September 5-6, 2018
Morgan Stanley – 16th Annual Global Healthcare Conference
New York, NY
September 12-14, 2018
Janney Montgomery Scott – Healthcare Conference 2018
New York, NY
September 17-18, 2018
Cantor Fitzgerald – Global Healthcare Conference 2018
New York, NY
October 1-3, 2018
Presentation dates and times will be updated on the Emergent website www.emergentbiosolutions.com under "Investors" as the information becomes available.

For these conferences, the company will be webcasting its presentation, which may include a discussion of the company’s recent business developments as well as its most recently reported financial results and guidance. The webcasts will be available both live and by replay, accessible from the Emergent website.